UCLA Health: Universal, Ready-To-Use Immunotherapy Detects and Destroys Endometrial Cancer
March 17, 2026
March 17, 2026
LOS ANGELES, California, March 17 (TNSjou) -- The UCLA Health issued the following news release:
* * *
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer
CAR-NKT cell therapy can be produced at a fraction of the cost of personalized treatments
*
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over th . . .
* * *
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer
CAR-NKT cell therapy can be produced at a fraction of the cost of personalized treatments
*
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over th . . .